AXA World Funds - US Growth A Capitalisation EUR logo

AXA World Funds - US Growth A Capitalisation EUR (AW4Y)

Market Open
20 Aug, 06:16
XMUN XMUN
1,012. 29
-0.2
-0.0198%
- Market Cap
- Div Yield
0 Volume
1,012.49
Previous Close
Add Transaction
Day Range
1,012.29 1,012.29
Year Range
843.31 1,030.06
Want to track AW4Y and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AW4Y trading today lower at €1,012.29, a decrease of -0.0198% from yesterday's close, completing a monthly increase of 1.7607% or €17.51. Over the past 12 months, AW4Y stock gained 7.0527%.
AW4Y is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

AW4Y Chart

AXA World Funds - US Growth A Capitalisation EUR (AW4Y) FAQ

What is the stock price today?

The current price is €1,012.29.

On which exchange is it traded?

AXA World Funds - US Growth A Capitalisation EUR is listed on XMUN.

What is its stock symbol?

The ticker symbol is AW4Y.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has AXA World Funds - US Growth A Capitalisation EUR ever had a stock split?

No, there has never been a stock split.

AXA World Funds - US Growth A Capitalisation EUR Profile

XMUN Exchange
United Kingdom Country

Overview

AXA World Funds - US Growth A Capitalisation EUR is an actively managed equity fund focused primarily on investing in the shares of large and mid-sized companies listed in the United States. The investment strategy aims to gain exposure to businesses that demonstrate above-average earnings growth, with an emphasis on sectors integral to the US growth equity landscape, including technology, consumer discretionary, health care, and communications services.

Operating under the AXA World Funds umbrella, this fund employs a fundamental and research-driven approach to stock selection. The management process prioritizes company quality, competitive positioning, and key structural growth drivers to ensure optimal investment outcomes. Investors should note that this share class is denominated in euro and is a capitalisation class; therefore, any income it generates is reinvested back into the fund instead of being disbursed as dividends. AXA World Funds - US Growth A Capitalisation EUR serves as a strategic tool for investors seeking dedicated access to US growth equities within a diversified portfolio, leveraging the extensive global research and portfolio management capabilities of AXA Investment Managers.

Products and Services

  • Equity Fund Management:

    The fund actively manages a portfolio of equities primarily from the US market, focusing on large and mid-sized companies exhibiting strong growth potential. This management is driven by in-depth research and analysis to identify firms with favorable growth characteristics.

  • Sector Diversification:

    AXA World Funds emphasizes investment across key sectors such as technology, consumer discretionary, health care, and communications services, ensuring a diversified approach that minimizes risk while maximizing growth opportunities.

  • Reinvestment Strategy:

    As a capitalisation class fund, any income generated from investments is reinvested in the fund, allowing for potential compounding of growth, rather than distributing it as dividends. This strategy aligns with long-term investment goals for wealth accumulation.

  • Global Research Capabilities:

    The fund benefits from the extensive research resources and analytical capabilities of AXA Investment Managers, which aids in informed stock selection and overall investment strategy formulation.

  • Investment Vehicle for US Growth Equities:

    AXA World Funds - US Growth A Capitalisation EUR provides investors with a focused approach to invest specifically in US growth equities, making it a suitable option for those seeking exposure to this dynamic market segment within a broader portfolio context.

Contact Information

Address: 22 Bishopsgate
Phone: 44 20 7003 1000